1,2-dichloroethane decreases expression ISO RGD:10463 6480464 ethylene dichloride results in decreased expression of DBI mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:10463 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DBI mRNA CTD PMID:22206623 1,4-dichlorobenzene increases expression ISO RGD:10463 6480464 4-dichlorobenzene results in increased expression of DBI mRNA CTD PMID:26975756 17alpha-ethynylestradiol multiple interactions ISO RGD:10463 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DBI mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of DBI mRNA CTD PMID:17108234 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:10463 6480464 Dihydrotestosterone results in increased expression of DBI mRNA CTD PMID:16963002 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736302 6480464 Dihydrotestosterone results in increased expression of DBI mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10463 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DBI mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DBI mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10463 6480464 Tetrachlorodibenzodioxin affects the expression of DBI mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DBI mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:10463 6480464 Glucosamine results in increased expression of DBI mRNA CTD PMID:17178593 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10463 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of DBI mRNA CTD PMID:23428407 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of DBI mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of DBI mRNA CTD PMID:19483382 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12376462 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of DBI mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:736302 6480464 Aflatoxin B1 results in increased methylation of DBI gene CTD PMID:27153756 aldehydo-D-glucosamine increases expression ISO RGD:10463 6480464 Glucosamine results in increased expression of DBI mRNA CTD PMID:17178593 aldehydo-D-glucose increases expression ISO RGD:10463 6480464 Glucose results in increased expression of DBI mRNA CTD PMID:17178593 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of DBI mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DBI mRNA CTD PMID:16483693 arsane multiple interactions ISO RGD:736302 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DBI mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:736302 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DBI mRNA CTD PMID:32525701 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of DBI mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:10463 6480464 Benzo(a)pyrene results in decreased expression of DBI mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:10463 6480464 Benzo(a)pyrene results in increased expression of DBI mRNA CTD PMID:22228805 benzo[b]fluoranthene decreases expression ISO RGD:736302 6480464 benzo(b)fluoranthene results in decreased expression of DBI mRNA CTD PMID:16269432 Benzo[k]fluoranthene decreases expression ISO RGD:10463 6480464 benzo(k)fluoranthene results in decreased expression of DBI mRNA CTD PMID:26377693 beta-D-glucosamine increases expression ISO RGD:10463 6480464 Glucosamine results in increased expression of DBI mRNA CTD PMID:17178593 bezafibrate increases expression ISO RGD:10463 6480464 Bezafibrate results in increased expression of DBI mRNA CTD PMID:17118139 bifenthrin multiple interactions EXP 6480464 bifenthrin analog inhibits the reaction [CGA results in increased expression of DBI mRNA] CTD PMID:21871944 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10463 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of DBI mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:10463 6480464 Diethylhexyl Phthalate results in increased expression of DBI mRNA CTD PMID:19245819 , PMID:19850644 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DBI mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DBI mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:736302 6480464 bisphenol A affects the expression of DBI mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DBI gene CTD PMID:28505145 bisphenol A increases methylation ISO RGD:10463 6480464 bisphenol A results in increased methylation of DBI promoter CTD PMID:27312807 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of DBI protein CTD PMID:25933445 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of DBI protein CTD PMID:28903499 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of DBI mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:736302 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DBI mRNA CTD PMID:29432896 cadmium atom decreases expression ISO RGD:736302 6480464 Cadmium results in decreased expression of DBI mRNA CTD PMID:24284285 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of DBI promoter CTD PMID:22457795 carbon nanotube affects expression ISO RGD:10463 6480464 Nanotubes, Carbon affects the expression of DBI protein CTD PMID:21135415 carbon nanotube decreases expression ISO RGD:10463 6480464 Nanotubes, Carbon analog results in decreased expression of DBI mRNA, Nanotubes, Carbon results in decreased expression of DBI mRNA CTD PMID:25620056 chloropicrin increases expression ISO RGD:736302 6480464 chloropicrin results in increased expression of DBI mRNA CTD PMID:26352163 cisplatin increases expression ISO RGD:736302 6480464 Cisplatin results in increased expression of DBI mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:736302 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of DBI mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:10463 6480464 Clofibrate results in increased expression of DBI mRNA CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of DBI mRNA, Clofibrate results in increased expression of DBI protein CTD PMID:12851107 , PMID:8499488 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of DBI mRNA CTD PMID:19483382 clofibrate multiple interactions ISO RGD:10463 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of DBI mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DBI mRNA] CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DBI mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of DBI mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:736302 6480464 cobaltous chloride results in decreased expression of DBI mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of DBI mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:736302 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DBI mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of DBI mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:736302 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DBI mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:736302 6480464 Copper Sulfate results in decreased expression of DBI mRNA CTD PMID:19549813 corticosterone increases expression ISO RGD:10463 6480464 Corticosterone results in increased expression of DBI mRNA CTD PMID:16963002 crocidolite asbestos increases expression ISO RGD:736302 6480464 Asbestos, Crocidolite results in increased expression of DBI mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:736302 6480464 Cyclosporine results in decreased expression of DBI mRNA CTD PMID:20106945 , PMID:25562108 cypermethrin decreases expression ISO RGD:10463 6480464 cypermethrin results in decreased expression of DBI mRNA CTD PMID:29020013 D-glucose increases expression ISO RGD:10463 6480464 Glucose results in increased expression of DBI mRNA CTD PMID:17178593 dexamethasone multiple interactions ISO RGD:10463 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of DBI mRNA CTD PMID:23428407 dexamethasone increases expression ISO RGD:736302 6480464 Dexamethasone results in increased expression of DBI mRNA CTD PMID:25047013 dibenz[a,h]anthracene decreases expression ISO RGD:736302 6480464 1 more ... CTD PMID:16269432 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of DBI mRNA CTD PMID:17379624 more ... dichloroacetic acid increases expression ISO RGD:10463 6480464 Dichloroacetic Acid results in increased expression of DBI mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:736302 6480464 dicrotophos results in decreased expression of DBI mRNA CTD PMID:28302478 disodium selenite increases expression ISO RGD:736302 6480464 Sodium Selenite results in increased expression of DBI mRNA CTD PMID:18175754 doxorubicin multiple interactions ISO RGD:10463 6480464 [docetaxel co-treated with Doxorubicin] results in increased expression of DBI protein CTD PMID:20457137 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of DBI mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:10463 6480464 Ethanol affects the expression of and affects the splicing of DBI mRNA CTD PMID:30319688 fenofibrate increases expression ISO RGD:10463 6480464 Fenofibrate results in increased expression of DBI mRNA CTD PMID:17118139 finasteride increases expression EXP 6480464 Finasteride results in increased expression of DBI mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:10463 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DBI mRNA CTD PMID:22206623 glucose increases expression ISO RGD:10463 6480464 Glucose results in increased expression of DBI mRNA CTD PMID:17178593 hydralazine multiple interactions ISO RGD:736302 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA CTD PMID:17183730 isobutanol multiple interactions ISO RGD:736302 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DBI mRNA CTD PMID:29432896 isotretinoin decreases expression ISO RGD:736302 6480464 Isotretinoin results in decreased expression of DBI mRNA CTD PMID:20436886 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of DBI mRNA CTD PMID:19483382 maneb multiple interactions ISO RGD:10463 6480464 [Paraquat co-treated with Maneb] results in decreased expression of DBI mRNA CTD PMID:18386188 menadione affects expression ISO RGD:736302 6480464 Vitamin K 3 affects the expression of DBI mRNA CTD PMID:20044591 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of DBI mRNA CTD PMID:30467583 methotrexate affects expression ISO RGD:10463 6480464 Methotrexate affects the expression of DBI mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:736302 6480464 Methyl Methanesulfonate results in decreased expression of DBI mRNA CTD PMID:23649840 methylazoxymethanol increases expression ISO RGD:10463 6480464 methylazoxymethanol results in increased expression of DBI mRNA CTD PMID:17107856 myristoyl-CoA affects binding ISO RGD:736302 6480464 S-tetradecanoyl-coenzyme A binds to DBI protein CTD PMID:17044054 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of DBI mRNA CTD PMID:16525678 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DBI mRNA CTD PMID:17602206 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of DBI mRNA CTD PMID:22110744 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of DBI mRNA CTD PMID:19483382 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DBI mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:10463 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of DBI mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DBI mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:736302 6480464 Acetaminophen results in decreased expression of DBI mRNA CTD PMID:21420995 , PMID:29067470 paraquat multiple interactions ISO RGD:10463 6480464 [Paraquat co-treated with Maneb] results in decreased expression of DBI mRNA CTD PMID:18386188 perfluorodecanoic acid increases expression EXP 6480464 perfluorodecanoic acid results in increased expression of DBI mRNA, perfluorodecanoic acid results in increased expression of DBI protein CTD PMID:8499488 perfluorohexanesulfonic acid increases expression ISO RGD:10463 6480464 perfluorohexanesulfonic acid results in increased expression of DBI mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:10463 6480464 perfluorononanoic acid results in increased expression of DBI mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10463 6480464 PPARA protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of DBI mRNA] CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10463 6480464 perfluorooctane sulfonic acid results in increased expression of DBI mRNA CTD PMID:28558994 perfluorooctanoic acid affects expression ISO RGD:10463 6480464 perfluorooctanoic acid affects the expression of DBI mRNA CTD PMID:18281256 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DBI mRNA, perfluorooctanoic acid results in increased expression of DBI protein CTD PMID:8499488 perfluorooctanoic acid increases expression ISO RGD:10463 6480464 perfluorooctanoic acid results in increased expression of DBI mRNA CTD PMID:17681415 , PMID:28558994 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of DBI mRNA CTD PMID:12376462 pirinixic acid multiple interactions ISO RGD:10463 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of DBI mRNA] CTD PMID:20059764 pirinixic acid increases expression ISO RGD:10463 6480464 pirinixic acid results in increased expression of DBI mRNA CTD PMID:17118139 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DBI mRNA CTD PMID:19162173 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of DBI mRNA CTD PMID:19483382 pirinixic acid multiple interactions EXP 6480464 pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to DBI promoter] CTD PMID:19103650 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of DBI mRNA CTD PMID:15686871 progesterone affects expression ISO RGD:10463 6480464 Progesterone affects the expression of DBI mRNA CTD PMID:17251523 sodium arsenate multiple interactions ISO RGD:736302 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DBI mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:736302 6480464 sodium arsenite results in increased expression of DBI mRNA CTD PMID:28595984 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of DBI protein CTD PMID:29459688 sodium fluoride decreases expression ISO RGD:10463 6480464 Sodium Fluoride results in decreased expression of DBI protein CTD PMID:28918527 tert-butyl hydroperoxide decreases expression ISO RGD:736302 6480464 tert-Butylhydroperoxide results in decreased expression of DBI mRNA CTD PMID:15336504 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DBI mRNA CTD PMID:16644059 , PMID:31150632 tetracycline decreases expression ISO RGD:10463 6480464 Tetracycline results in decreased expression of DBI mRNA CTD PMID:16917069 thapsigargin decreases expression ISO RGD:736302 6480464 Thapsigargin results in decreased expression of DBI mRNA CTD PMID:22378314 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of DBI mRNA CTD PMID:19483382 titanium dioxide decreases expression ISO RGD:10463 6480464 titanium dioxide results in decreased expression of DBI mRNA CTD PMID:23557971 toluene decreases expression EXP 6480464 Toluene results in decreased expression of DBI mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DBI mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:10463 6480464 tributyltin results in increased expression of DBI mRNA CTD PMID:23428407 troglitazone increases expression ISO RGD:10463 6480464 troglitazone results in increased expression of DBI mRNA CTD PMID:12732648 tungsten increases expression ISO RGD:10463 6480464 Tungsten results in increased expression of DBI mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:736302 6480464 Tunicamycin results in decreased expression of DBI mRNA CTD PMID:22378314 , PMID:29453283 valproic acid multiple interactions ISO RGD:736302 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:10463 6480464 Valproic Acid affects the expression of DBI mRNA CTD PMID:17292431 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DBI mRNA CTD PMID:15686871 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of DBI mRNA CTD PMID:23034163 
Gene-Chemical Interaction Annotations
